Profile of SARS-CoV-2

被引：4

作者：

Heinz, Franz X. ^{[1
]}

Stiasny, Karin ^{[1
]}

机构：

[1] Med Univ Vienna, Ctr Virol, Kinderspitalgasse 15, A-1090 Vienna, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2020年 / 132卷 / 21-22期

关键词：

COVID-19; Coronavirus; Origin and evolution; Vaccines; Antivirals; COVID-19; SPIKE;

D O I：

10.1007/s00508-020-01763-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The recent emergence of a new coronavirus (severe acute respiratory syndrome corona-virus-2, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and/or death has become a global threat to public health and economy. In this article, we describe some of the most important characteristics of this new virus (including gaps in our understanding) and provide a perspective of ongoing activities for developing virus-specific countermeasures, such as vaccines and antiviral drugs.

引用

页码：635 / 644

页数：10

共 91 条

[1] Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial [J].

Abella, Benjamin S. ;

Jolkovsky, Eliana L. ;

Biney, Barbara T. ;

Uspal, Julie E. ;

Hyman, Matthew C. ;

Frank, Ian ;

Hensley, Scott E. ;

Gill, Saar ;

Vogl, Dan T. ;

Maillard, Ivan ;

Babushok, Daria, V ;

Huang, Alexander C. ;

Nasta, Sunita D. ;

Walsh, Jennifer C. ;

Wiletyo, E. Paul ;

Gimotty, Phyllis A. ;

Milone, Michael C. ;

Amaravadi, Ravi K. .

JAMA INTERNAL MEDICINE, 2021, 181 (02) :195-202

[2] Aging immunity may exacerbate COVID-19 [J].

Akbar, Arne N. ;

Gilroy, Derek W. .

SCIENCE, 2020, 369 (6501) :256-257

[3] The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development [J].

Alturki, Sana O. ;

Alturki, Sawsan O. ;

Connors, Jennifer ;

Cusimano, Gina ;

Kutzler, Michele A. ;

Izmirly, Abdullah M. ;

Haddad, Elias K. .

FRONTIERS IN IMMUNOLOGY, 2020, 11

[4] The proximal origin of SARS-CoV-2 [J].

Andersen, Kristian G. ;

Rambaut, Andrew ;

Lipkin, W. Ian ;

Holmes, Edward C. ;

Garry, Robert F. .

NATURE MEDICINE, 2020, 26 (04) :450-452

[5]

[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461

[6] A perspective on potential antibody-dependent enhancement of SARS-CoV-2 [J].

Arvin, Ann M. ;

Fink, Katja ;

Schmid, Michael A. ;

Cathcart, Andrea ;

Spreafico, Roberto ;

Havenar-Daughton, Colin ;

Lanzavecchia, Antonio ;

Corti, Davide ;

Virgin, Herbert W. .

NATURE, 2020, 584 (7821) :353-363

[7] Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium [J].

Boettcher-Friebertshaeuser, Eva ;

Klenk, Hans-Dieter ;

Garten, Wolfgang .

PATHOGENS AND DISEASE, 2013, 69 (02) :87-100

[8] SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 [J].

Braun, Julian ;

Loyal, Lucie ;

Frentsch, Marco ;

Wendisch, Daniel ;

Georg, Philipp ;

Kurth, Florian ;

Hippenstiel, Stefan ;

Dingeldey, Manuela ;

Kruse, Beate ;

Fauchere, Florent ;

Baysal, Emre ;

Mangold, Maike ;

Henze, Larissa ;

Lauster, Roland ;

Mall, Marcus A. ;

Beyer, Kirsten ;

Roehmel, Jobst ;

Voigt, Sebastian ;

Schmitz, Juergen ;

Miltenyi, Stefan ;

Demuth, Ilja ;

Mueller, Marcel A. ;

Hocke, Andreas ;

Witzenrath, Martin ;

Suttorp, Norbert ;

Kern, Florian ;

Reimer, Ulf ;

Wenschuh, Holger ;

Drosten, Christian ;

Corman, Victor M. ;

Giesecke-Thiel, Claudia ;

Sander, Leif Erik ;

Thiel, Andreas .

NATURE, 2020, 587 (7833) :270-+

[9] Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions [J].

Bunders, Madeleine J. ;

Altfeld, Marcus .

IMMUNITY, 2020, 53 (03) :487-495

[10]

Burton DR, 2020, HOST MICROBE, V27, p5 695 698, DOI [10.1016/j.chom.2020.04.022, DOI 10.1016/J.CHOM.2020.04.022]

← 1 2 3 4 5 6 7 8 9 10 →